Danish technology board investigates implants:
This article was originally published in Clinica
The Danish board of technology, which assesses new technology and provides advice to the Danish parliament, has initiated a project investigating the use of implants in Denmark. According to EU regulations, if a product is accepted by a notified body in one EU country, then it must be accepted in all other member states. Unfortunately, claims the board, neither manufacturers not authorities in Denmark have confidence in this process. There is a large discrepancy between safety demands on new medicines and implants, especially in the area of post market surveillance, it says.
You may also be interested in...
COVID-19 Vaccines: ACIP’s Allocation Proposal Prioritizes Long-Term Care Residents, Essential Workers
First group to receive vaccine would comprise health care personnel and residents of long-term care facilities; next in line are non-health care essential workers, who would take priority over adults with high-risk medical conditions and those ages 65 years and older, according to the CDC advisory committee’s proposed allocation framework.
Azar says ACIP’s prioritization recommendations should carry weight, but states will be final arbiter of who is vaccinated.
Sanofi R&D head John Reed says the company has kept 95% of patients on its nearly 400 clinical trials, started 59 studies, and benefited from its in-house drug supply management.